Barriers to Cancer Care in the LGBTQ+ Community.

IF 2 3区医学 Q3 ONCOLOGY

Journal of Surgical Oncology Pub Date : 2024-11-11 DOI:10.1002/jso.27980

Shebiki Beaton, Tamra McKenzie-Johnson

引用次数: 0

Abstract

Individuals that identify as lesbian, gay, bisexual, transgender, queer, intersex, and asexual (LGBTQIA) make up a medically underserved population, that experience disparities in cancer care. Specific cancer incidence and mortality in this population is understudied, as national cancer registries and cancer surveys have limited data about sexual orientation or gender identity. The LGBTQIA community face disparate cancer outcomes in prevention, screening, diagnosis, and treatment due to barriers that limit access to cancer care. To better understand these concerns, we will take a deep dive into the three primary barriers that prevent access to cancer care: personal, provider and systems barriers.

查看原文本刊更多论文

LGBTQ+ 群体癌症护理的障碍。

被认定为女同性恋、男同性恋、双性恋、变性人、同性恋者、双性人和无性人（LGBTQIA）的人是医疗服务不足的人群，他们在癌症护理方面存在差异。由于国家癌症登记处和癌症调查中有关性取向或性别认同的数据有限，因此对这一人群的具体癌症发病率和死亡率研究不足。LGBTQIA 群体在癌症预防、筛查、诊断和治疗方面面临着不同的结果，这是因为他们在获得癌症治疗方面存在障碍。为了更好地了解这些问题，我们将深入探讨阻碍获得癌症治疗的三个主要障碍：个人障碍、提供者障碍和系统障碍。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Surgical Oncology 医学-外科

CiteScore

4.70

自引率

4.00%

发文量

367

审稿时长

2 months

期刊介绍： The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.